Diagnosis of Hyperaldosteronism vs Other Adrenal Masses
For diagnosing hyperaldosteronism versus other adrenal masses, the aldosterone-to-renin ratio (ARR) is the preferred initial test in patients with hypertension and/or hypokalemia, with a value ≥20 ng/dL per ng/mL/hr having excellent sensitivity and specificity (>90%) for confirming hyperaldosteronism. 1
Initial Evaluation for Hyperaldosteronism
Clinical Indicators to Suspect Hyperaldosteronism
- Hypertension with hypokalemia (spontaneous or diuretic-induced)
- Resistant hypertension
- Early-onset hypertension or family history of early-onset hypertension
- Symptoms such as muscle cramping, weakness, headaches, or intermittent paralysis 2
Laboratory Testing
Aldosterone-to-Renin Ratio (ARR):
- Must be performed under specific conditions:
- Morning collection (after patient has been out of bed for 2 hours)
- Patient seated for 5-15 minutes before collection
- Patient should be potassium-replete
- Interfering medications should be discontinued when possible 1
- Interpretation:
- Must be performed under specific conditions:
Confirmatory Testing (if ARR is positive):
Imaging
- Non-contrast CT scan of adrenal glands (or MRI if CT is contraindicated) after biochemical confirmation 2
- Imaging helps identify adrenal nodules but cannot reliably distinguish between functional and non-functional masses 1
Adrenal Vein Sampling
- Gold standard for distinguishing between unilateral and bilateral aldosterone production
- Essential before considering adrenalectomy, particularly in:
- Patients >40 years old
- Normal-appearing adrenal glands on imaging
- Discordance between biochemical and imaging results 2
Differential Diagnosis of Adrenal Masses
1. Cortisol-Secreting Lesions
- Screening Test: 1 mg overnight dexamethasone suppression test (DST) for all adrenal incidentalomas 1
- Interpretation:
- <50 nmol/L excludes cortisol hypersecretion
- 51-138 nmol/L suggests possible autonomous cortisol secretion
138 nmol/L indicates cortisol hypersecretion 1
- Additional Testing: Plasma ACTH, 24-hr urinary-free cortisol, midnight salivary cortisol 1
2. Pheochromocytoma
- Indications for Testing:
- Adrenal incidentalomas with ≥10 HU on non-contrast CT
- Signs/symptoms of catecholamine excess (headaches, anxiety attacks, sweating, palpitations) 1
- Screening Test: Plasma free metanephrines or 24-hour urinary metanephrines 1
- Interpretation: >2× upper limit of normal is diagnostic 1
3. Adrenocortical Carcinoma
- Indications for Testing:
- Suspected ACC
- Clinical signs of virilization 1
- Testing: DHEAS, testosterone, and other androgens 1
- Additional Testing: 17b-estradiol, 17-OH progesterone, androstenedione, 17-OH pregnenolone, 11-deoxycorticosterone, progesterone, and estradiol 1
Management Considerations
For Hyperaldosteronism
Unilateral Disease: Laparoscopic adrenalectomy is treatment of choice
Bilateral Disease or Non-surgical Candidates: Medical therapy with mineralocorticoid receptor antagonists (spironolactone or eplerenone) 1, 2
Important Pitfalls to Avoid
Medication Interference with ARR Testing:
- Discontinue beta-blockers, centrally acting drugs, diuretics, and mineralocorticoid receptor antagonists when feasible
- Long-acting calcium channel blockers and alpha-receptor antagonists have minimal interference and can be continued 2
Interpretation Challenges:
Diagnostic Accuracy:
By following this systematic approach to evaluating adrenal masses, hyperaldosteronism can be accurately diagnosed and distinguished from other adrenal pathologies, leading to appropriate treatment decisions and improved patient outcomes.